Renji Hospital
Clinical trials sponsored by Renji Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kidney cancer: experimental combo targets resistant tumors Results expected Oct 2026 (estimated)
- New Clot-Busting technique could reduce Long-Term leg damage Results expected Oct 2026 (estimated)
- Could new imaging probes spot breast cancer more accurately? Results expected Nov 2026 (estimated)
- New PET scan agent could spot kidney cancer more accurately Results expected Nov 2026 (estimated)
- New drug cocktail aims to wipe out breast cancer before surgery Results expected Dec 2026 (estimated)
-
New combo aims to control resistant liver cancer
Disease control Stopped earlyThis study tested whether adding an experimental drug (VIC-1911) to the standard drug lenvatinib could help people with liver cancer that no longer responds to lenvatinib alone. Only 5 people were enrolled before the study was stopped early. The goal was to see if the combination…
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
A tiny dose of an old drug might stop Post-Surgery brain fog in seniors
Prevention Stopped earlyThis trial tests whether a single low dose of droperidol, given just before the end of surgery, can prevent postoperative delirium—a state of confusion and disorientation—in adults aged 65 and older undergoing non-cardiac surgery. About 800 participants will receive either droper…
Sponsor: RenJi Hospital • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC